Lannett Company, Inc.  

(Public, NYSE:LCI)   Watch this stock  
Find more results for Cody Smith
62.40
-2.77 (-4.25%)
Feb 27 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 62.16 - 65.15
52 week 29.12 - 65.69
Open 65.02
Vol / Avg. 944,173.00/802,910.00
Mkt cap 2.23B
P/E 18.27
Div/yield     -
EPS 3.41
Shares 35.80M
Beta 1.20
Inst. own 56%
May 5, 2015
Q3 2015 Lannett Company Inc Earnings Release (Estimated) - 4:00PM EDT - Add to calendar
Mar 9, 2015
Lannett Company Inc at ROTH Conference - 2:30PM EDT - Add to calendar
Feb 24, 2015
Lannett Company Inc at RBC Healthcare Conference
Feb 11, 2015
Lannett Company Inc at Leerink Global Healthcare Conference
Feb 4, 2015
Q2 2015 Lannett Company Inc Earnings Call
Feb 4, 2015
Q2 2015 Lannett Company Inc Earnings Release
Jan 26, 2015
Preliminary Q2 2015 Lannett Company Inc Earnings Release
Jan 21, 2015
Lannett Company Inc Annual Shareholders Meeting
Jan 14, 2015
Lannett Company Inc at JPMorgan Healthcare Conference
Dec 10, 2014
Lannett Company Inc at Oppenheimer Healthcare Conference
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '14) 2014
Net profit margin 39.04% 20.88%
Operating margin 57.95% 32.18%
EBITD margin - 34.37%
Return on average assets 45.07% 22.39%
Return on average equity 50.51% 27.00%
Employees 399 -
CDP Score - -

Address

9000 State Rd
PHILADELPHIA, PA 19136-1615
United States - Map
+1-215-3339000 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Lannett Company, Inc. develops, manufactures, packages, markets and distributes solid oral (tablets and capsules), extended release, topical and oral solution finished dosage forms of drugs. The Company also manufactures active pharmaceutical ingredients through its Cody Laboratories, Inc. (Cody Labs) subsidiary. The Company operates pharmaceutical manufacturing plants in Philadelphia, Pennsylvania and Cody, Wyoming. Customers of the Company�s pharmaceutical products include generic pharmaceutical distributors, drug wholesalers, chain drug stores, private label distributors, mail-order pharmacies, other pharmaceutical manufacturers, managed care organizations, hospital buying groups, Governmental entities and health maintenance organizations. The Company�s products include Levothyroxine Sodium tablets, Digoxin tablets, Butalbital, Cocaine Topical Solution and Morphine Sulfate Oral Solution.

Officers and directors

Jeffrey Farber Chairman of the Board
Age: 53
Bio & Compensation  - Reuters
Michael J. Bogda President
Age: 53
Bio & Compensation  - Reuters
Arthur P. Bedrosian J.D. Chief Executive Officer, Director
Age: 68
Bio & Compensation  - Reuters
Martin P. Galvan CPA Chief Financial Officer, Vice President - Finance, Treasurer
Age: 61
Bio & Compensation  - Reuters
William F. Schreck Chief Operating Officer
Age: 65
Bio & Compensation  - Reuters
Robert Ehlinger Vice President - Logistics, Chief Information Officer
Age: 56
Bio & Compensation  - Reuters
Kevin R. Smith Vice President - Sales and Marketing
Age: 53
Bio & Compensation  - Reuters
William R. Farber Ph.D. Chairman Emeritus
Age: 82
Bio & Compensation  - Reuters
David Drabik Independent Director
Age: 45
Bio & Compensation  - Reuters
James M. Maher Independent Director
Age: 61
Bio & Compensation  - Reuters